Earnings Preview: Key Expectations for AstraZeneca, Nucor, Celestica
- July 25th, 2026
- 104 views
LAS VEGAS, NV / CRWE PRESS RELEASE / July 25, 2026 - Several companies are expected to unveil their financial results on Monday, July 27, including:
AstraZeneca PLC (NYSE: AZN), the global biopharmaceutical company known for its portfolio of oncology, cardiovascular, and rare disease treatments, will release its first-half and second quarter 2026 results before the stock market opens. Wall Street expects earnings per share (EPS) of $1.27 on revenue of $15.43 billion. $AZN closed at $169.26 on Friday, gaining $0.99 (0.59%).
Nucor Corporation (NYSE: NUE), one of North America's largest steel producers, plans to report its second quarter fiscal 2026 earnings after the markets close. The consensus estimate calls for EPS of $4.53 on revenue of $10.13 billion. $NUE ended Friday's session at $247.56, advancing $6.41 (2.66%).
Celestica Inc. (NYSE: CLS) (TSX: CLS), a provider of manufacturing, hardware platform, and supply chain solutions for technology customers, will release its second quarter 2026 financial results following the closing bell. Analysts anticipate EPS of $2.31 on revenue of $4.39 billion. $CLS closed at $305.28 on Friday, declining $29.47 (8.80%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
FDA Issues Emergency Use Authorization for Drug to Treat New World Screwworm in Dogs and Puppies
August 13th, 2026August 12th, 2026August 11th, 2026For College Athletes, NIL Starts with Reputation
August 11th, 2026Inside the NJCP Player Pathway
August 10th, 2026




Member Login